Literature DB >> 15978225

Acute urinary retention in men: the risks and outcomes with medical therapy.

Timothy B Hargreave1, Alan S McNeill.   

Abstract

This paper is restricted to the discussion of the relatively modern disorder of sudden painful inability to urinate in older men. It was not a common medical problem until the 19th century when, in developed countries, male life expectancy increased to beyond 60 years; it remains an uncommon problem in those developing countries where male life expectancy remains low, particularly in some sub-Saharan African countries where male life expectancy is only 44.8 years.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978225     DOI: 10.1007/s11934-005-0019-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  53 in total

1.  Changes in the development of experimental autoimmune prostatitis (EAP) by castration in aged rats.

Authors:  G Morón; B Maletto; A Rópolo; M C Pistoresi-Palencia
Journal:  Dev Comp Immunol       Date:  2000 Sep-Oct       Impact factor: 3.636

2.  Does ultrastructural morphology of human detrusor smooth muscle cells characterize acute urinary retention?

Authors:  Nina Raae Holm; Thomas Horn; Frank Smedts; Jørgen Nordling; Jean de la Rossette
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

3.  Post-operative urinary infection and septicaemia in urology.

Authors:  M T Cafferkey; B Conneely; F R Falkiner; W A Gillespie; D Murphy
Journal:  J Hosp Infect       Date:  1980-12       Impact factor: 3.926

4.  Morbidity and the impact on daily activities associated with catheter drainage after acute urinary retention.

Authors:  B Khoubehi; N A Watkin; A D Mee; C W Ogden
Journal:  BJU Int       Date:  2000-06       Impact factor: 5.588

5.  Prostatic infarction/infection in acute urinary retention secondary to benign prostatic hyperplasia.

Authors:  I Anjum; M Ahmed; A Azzopardi; G R Mufti
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

6.  European collaborative study of antibiotic prophylaxis for transurethral resection of the prostate.

Authors:  T B Hargreave; H Botto; G H Rikken; J R Hindmarsh; T E McDermott; O K Mjolnerod; P Petays; K Schalkhäuser; A Stellos
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

7.  A survey of koala road kills in New South Wales.

Authors:  P J Canfield
Journal:  J Wildl Dis       Date:  1991-10       Impact factor: 1.535

8.  Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.

Authors:  Gerald Andriole; David Bostwick; Otis Brawley; Leonard Gomella; Michael Marberger; Donald Tindall; Sharon Breed; Matt Somerville; Roger Rittmaster
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

9.  Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.

Authors:  Claus G Roehrborn; Peter Boyle; J Curtis Nickel; Klaus Hoefner; Gerald Andriole
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

10.  The use of alpha-adrenergic blockers in benign prostatic obstruction.

Authors:  M Caine; A Pfau; S Perlberg
Journal:  Br J Urol       Date:  1976-08
View more
  3 in total

Review 1.  Acute urinary retention: who is at risk and how best to manage it?

Authors:  Anand Patel; Christopher Chapple
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

2.  Personalized therapeutics of α₁-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Authors:  Ling-ling Zhu; Zhi-jun Feng; Quan Zhou
Journal:  Clin Interv Aging       Date:  2015-03-26       Impact factor: 4.458

Review 3.  A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia.

Authors:  J C Nickel; S Sander; T D Moon
Journal:  Int J Clin Pract       Date:  2008-10       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.